Cannabis-Related Psychosis: Trauma, Risk, and Response
Cannabis-Related Psychosis: Trauma, Risk, and Response
Information
Date & Time
-
-
Learning Objectives
Participants will be able to:
-
Explain three neurobiological effects of THC and how increased potency may influence mental health outcomes.
-
Describe three shifts in cannabis potency, product forms, and retail landscape distinguishing today's market from prior decades.
-
Identify three ways trauma-related dysregulation can function as an underlying driver of cannabis use as a coping mechanism, distinct from recreational or exploratory use.
-
Differentiate cannabis-related psychosis from primary psychotic disorders based on clinical presentation and history, citing at least four key clinical distinctions.
-
Apply at least three trauma-informed assessment strategies when working with clients and families impacted by cannabis-related concerns.
Educational Goal
Description
As cannabis legalization and commercialization expand, patterns of use have shifted significantly. Today’s products differ in potency, delivery methods, and accessibility, creating confusion about risk among parents, providers, and clients. This training examines contemporary cannabis trends and their clinical implications, including cannabis-related psychosis. Participants will review how THC affects the brain, how high-potency products may increase vulnerability, and how factors such as early onset of use, trauma exposure, frequency, and family history contribute to risk. Trauma-informed assessment and clinical response strategies will be discussed.
Target Audience
- Addiction Professional
- Counselor
- Marriage & Family Therapist
- Psychologist
- Social Worker
Presenters
Financially Sponsored By
- Integrated Care Concepts and Consultation